MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Trial of D-Cycloserine in Schizophrenia
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT00000371
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Phase 3
Completed
- Conditions
- ArrhythmiaCardiovascular DiseasesAtrial FibrillationHeart DiseasesThrombophlebitisCerebrovascular AccidentCerebral Embolism and ThrombosisCerebrovascular Disorders
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2014-04-10
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT00000517
© Copyright 2025. All Rights Reserved by MedPath